Abstract
The microbiota is pivotal in orchestrating the pathogenesis of IBD-associated colorectal cancer (CRC). We recently demonstrated that altered elements in the microbiota of inflammasome-deficient mice drive transmissible inflammation-induced CRC. This microbiota-mediated effect is dependent upon microbiome-induced CCL5-driven inflammation, which, in turn, promotes epithelial cell proliferation through local activation of the IL-6 pathway, leading to cancer development.
Original language | English |
---|---|
Article number | 981995 |
Number of pages | 3 |
Journal | OncoImmunology |
Volume | 8 |
Issue number | 10 |
Early online date | 7 May 2018 |
DOIs | |
State | Published - 3 Oct 2019 |